The Correlation between Vitamin D Levels and the Risk of Postoperative Recurrence in Crohn’s Disease
- 8 February 2021
- journal article
- research article
- Published by S. Karger AG in Digestion
- Vol. 102 (5), 767-775
- https://doi.org/10.1159/000513589
Abstract
Background and Aims: Vitamin D deficiency has been associated with disease activity in Crohn’s disease (CD). We assessed whether there is a correlation between vitamin D levels and the risk of postoperative recurrence in CD. Methods: CD patients who underwent surgery were identified from a prospectively maintained database at the University of Chicago. The primary endpoint was the correlation of serum 25-hydroxy vitamin D levels measured at 6–12 months after surgery and the proportion of patients in endoscopic remission, defined as a simple endoscopic score for CD of 0. Clinical, biological (C-reactive protein), and histologic recurrences were also studied. Results: Among a total of 89 patients, 17, 46, and 26 patients had vitamin D levels of 30 ng/mL, respectively. Patients with higher vitamin D levels were significantly more likely to be in endoscopic remission compared to those with lower levels (23, 42, and 67% in ascending tertile order; p = 0.028). On multivariate analysis, vitamin D >30 ng/mL (odds ratio [OR] 0.22, 95% confidence interval [CI] 0.07–0.66, p = 0.006) and anti-tumor necrosis factor agent treatment (OR 0.25, 95% CI 0.08–0.83, p = 0.01) were associated with reduced risk of endoscopic recurrence. Rates of clinical, biological, and histologic remission trended to be higher in patients with higher vitamin D levels (p = 0.17, 0.55, 0.062, respectively). Conclusion: In the present study, higher vitamin D level was associated with lower risk of postoperative endoscopic CD recurrence. Further, studies are warranted to assess the role of vitamin D in postoperative CD recurrence.Keywords
This publication has 35 references indexed in Scilit:
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Prevalence and Risk Factors for Hypovitaminosis D in Young Patients With Inflammatory Bowel DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2011
- Vitamin D Deficiency in Patients With Inflammatory Bowel DiseaseJournal of Parenteral and Enteral Nutrition, 2011
- Vitamin D and mucosal immune functionCurrent Opinion in Gastroenterology, 2010
- Clinical trial: vitamin D3 treatment in Crohn’s disease – a randomized double‐blind placebo‐controlled studyAlimentary Pharmacology & Therapeutics, 2010
- Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trialGut, 2010
- Direct and Indirect Induction by 1,25-Dihydroxyvitamin D3 of the NOD2/CARD15-Defensin β2 Innate Immune Pathway Defective in Crohn DiseaseJournal of Biological Chemistry, 2010
- Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's diseaseGastrointestinal Endoscopy, 2006
- Endoscopic and histologic evidence of persistent mucosal healing and correlation with clinical improvement following sustained infliximab treatment for Crohn's diseaseCurrent Medical Research and Opinion, 2005
- Controlled trial of metronidazole treatment for prevention of crohn's recurrence after ileal resectionGastroenterology, 1995